Rosiello Robert L. 4
4 · Evelo Biosciences, Inc. · Filed Apr 18, 2023
Insider Transaction Report
Form 4
Rosiello Robert L.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-04-14+40,000→ 40,000 totalExercise: $0.17Exp: 2033-04-14→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years.